Combination therapyutilizing a GLP-1 for appetite control alongside a novel peptide for metabolic supportis highly effective for breaking plateaus without escalating standard doses
A single subcutaneous injection kept GH 2- to 10-fold elevated for at least 6 days and IGF-1 1.5- to 3-fold for 9-11 days , with a half-life of 5.8-8.1 days [PMID 16352683]
What Does the Published Research Say
Recent Advances in Our Understanding of Mast Cell Activation or Should It Be Mast Cell Mediator Disorders? Expert Review of Clinical Immunology, vol
The Patel 2016 study cited earlier compared sublingual absorption of sermorelin (3,358 Da) to sublingual testosterone (288 Da) and found a 7-fold difference in mucosal permeability
Kojima K, Ruvolo V, Wei W, Huang Z, Duvvuri S, Vassilev L, Nichols G, Rueger R, Borthakur G, Konopleva M, Samaniego F, Younes A, O'Brien S, Andreeff M